Table 3.
References | Judgment criteria | Resistance rate to common antibioticsa (%) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
PEN | AMX | AMC | FEP | CTX | CXM | CRO | CEC | IPM | MEM | ERY | ||
[17] | CLSI 2008 |
Nonmeningitis isolates 0 Meningitis isolates 76.6 |
- | 0.6 | - | - | 62.0 |
Nonmeningitis isolates 0 Meningitis isolates 29.8 |
- | 0 | - | 95.9 |
[24] | CLSI 2014 |
Nonmeningitis isolates 0 Meningitis isolates 50.0 |
- | 0 | - | - | - |
Nonmeningitis isolates 0 Meningitis isolates 2.9 |
- | - | - | 100 |
[25] | CLSI 2017 |
Nonmeningitis isolates 0 Meningitis isolates 95.7 |
- | 0 | - | - | 75.7 |
Nonmeningitis isolates 1.1 Meningitis isolates 13.0 |
- | 0 | - | 99.1 |
[26] | CLSI 2010 |
Nonmeningitis isolates 1.3 Meningitis isolates 100 |
- | 0 | - | - | 79.3 |
Nonmeningitis isolates 3.8 Meningitis isolates 33.3 |
81.6 | 0 | - | 96.6 |
[28] | CLSI 2013 | 53.3 | 46.6 | - | 40.0 | 26.7 | - | - | - | - | 63.3 | 96.7 |
[29]b | CLSI 2008 | 20.58 | 5.88 | - | - | 11.76 | - | 11.76 | - | - | 11.76 | 95.58 |
[29]c | CLSI 2008 | 36.36 | 5.45 | - | - | 19.09 | - | 16.36 | - | - | 12.72 | 98.18 |
[30] | CLSI 2013 | 71 | 7 | - | - | 29 | - | - | - | - | - | 100 |
[31] | CLSI 2009 | 39.21 | 34.31 | - | 15.96 | 13.83 | - | - | - | - | 40.43 | 100 |
[32] | CLSI 2008 | 53.97 | 14.29 | - | - | 9.52 | - | 9.52 | - | 3.85 | - | 85.71 |
[33] | CLSI 2012 | 43.6 | - | 19.4 | - | - | 63.3 | 27.4 | - | - | - | 95.2 |
[34] | CLSI 2008 | 42.11 | - | - | - | 23.53 | - | - | - | - | - | 94.74 |
aAbbreviations for common antibiotics: PEN, penicillin; AMX, amoxicillin; AMC, amoxicillin-clavulanic acid; FEP, cefepime; CTX, cefotaxime; CXM, cefuroxime; CRO, ceftriaxone; CEC, cefaclor; IPM, imipenem; MEM, meropenem; ERY, erythromycin
bIsolates included in reference [11] contained two parts, and these parts were from Shanghai
cIsolates included in reference [12] contained two parts, and these parts were from Lanzhou, Gansu